Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-(CAS: 142217-78-5)

This compound is subject to various regulatory guidelines such as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, FDA requirements for pharmaceuticals, and EPA guidelines for environmental protection. Specific safety data sheets (SDS) should be consulted for detailed handling and storage procedures.

There are alternative reagents such as analogs with similar functional groups, isomers, or related compounds. Common alternatives include various purines and their derivatives, which can serve similar roles in chemical synthesis depending on the specific reaction requirements.

Research and market trends for this compound are closely linked to pharmaceutical and biotechnology advancements. There is a growing interest in purine-based drugs and their applications in treating various diseases. Market trends indicate increasing demand for this compound in developing new therapeutic agents and research tools.

Waste containing this compound should be collected and disposed of in accordance with local and national regulations. Waste should be neutralized and inactivated before disposal. Incineration or professional waste disposal services should be used. Environmental precautions include proper containment to prevent release into the environment and adherence to all safety protocols during handling and disposal.